Christel Devaud

2.5k total citations · 1 hit paper
27 papers, 1.9k citations indexed

About

Christel Devaud is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Christel Devaud has authored 27 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 19 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Christel Devaud's work include Immune Cell Function and Interaction (17 papers), CAR-T cell therapy research (12 papers) and Immunotherapy and Immune Responses (12 papers). Christel Devaud is often cited by papers focused on Immune Cell Function and Interaction (17 papers), CAR-T cell therapy research (12 papers) and Immunotherapy and Immune Responses (12 papers). Christel Devaud collaborates with scholars based in Australia, France and United States. Christel Devaud's co-authors include Phillip K. Darcy, Michael H. Kershaw, Liza B. John, Mark J. Smyth, Carmen S. Yong, Paul A. Beavis, Melvyn T. Chow, Connie P.M. Duong, Jennifer A. Westwood and Nicole M. Haynes and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

In The Last Decade

Christel Devaud

26 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells

2013 571 citations Liza B. John, Christel Devaud et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christel Devaud Australia	16	1.4k	1.0k	441	322	292	27	1.9k
Liza B. John Australia	16	1.7k 1.3×	1.2k 1.2×	612 1.4×	399 1.2×	389 1.3×	27	2.4k
Clare Y. Slaney Australia	23	1.8k 1.3×	1.2k 1.2×	761 1.7×	304 0.9×	434 1.5×	38	2.6k
Stefanie R. Bailey United States	19	1.6k 1.2×	1.1k 1.1×	699 1.6×	383 1.2×	468 1.6×	35	2.3k
Kelsey M. Wanhainen United States	10	1.7k 1.2×	776 0.8×	551 1.2×	436 1.4×	582 2.0×	14	1.9k
Junyun Lai Australia	13	819 0.6×	697 0.7×	336 0.8×	137 0.4×	182 0.6×	16	1.2k
Kheng Newick United States	14	1.9k 1.4×	897 0.9×	819 1.9×	445 1.4×	608 2.1×	15	2.4k
Özcan Met Denmark	29	1.5k 1.1×	1.5k 1.5×	591 1.3×	236 0.7×	163 0.6×	81	2.3k
Kathleen B. Yates United States	18	1.5k 1.1×	1.9k 1.9×	1.1k 2.5×	171 0.5×	92 0.3×	28	3.0k
Elke Firat Germany	21	769 0.6×	561 0.6×	750 1.7×	108 0.3×	143 0.5×	37	1.6k
Imran G. House Australia	12	700 0.5×	642 0.6×	306 0.7×	117 0.4×	127 0.4×	14	1.1k

Countries citing papers authored by Christel Devaud

Since Specialization

Citations

This map shows the geographic impact of Christel Devaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christel Devaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christel Devaud more than expected).

Fields of papers citing papers by Christel Devaud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christel Devaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christel Devaud. The network helps show where Christel Devaud may publish in the future.

Co-authorship network of co-authors of Christel Devaud

This figure shows the co-authorship network connecting the top 25 collaborators of Christel Devaud. A scholar is included among the top collaborators of Christel Devaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christel Devaud. Christel Devaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Raymond, Benjamin B. A., Marie Locard‐Paulet, Marieke E. Ijsselsteijn, et al.. (2024). The C-type lectin DCIR contributes to the immune response and pathogenesis of colorectal cancer. Scientific Reports. 14(1). 7199–7199. 3 indexed citations

Féliu, Virginie, Carlos Gomez‐Roca, Émeline Sarot, et al.. (2023). Distant antimetastatic effect of enterotropic colon cancer–derived α4β7 ⁺ CD8 ⁺ T cells. Science Immunology. 8(84). eadg8841–eadg8841. 9 indexed citations

Gravelle, Pauline, Frédéric Pont, Christel Devaud, et al.. (2021). Phased differentiation of γδ T and T CD8 tumor-infiltrating lymphocytes revealed by single-cell transcriptomics of human cancers. OncoImmunology. 10(1). 1939518–1939518. 17 indexed citations

Martínez, Alejandra, Jean‐Pierre Delord, Maha Ayyoub, & Christel Devaud. (2020). Preclinical and Clinical Immunotherapeutic Strategies in Epithelial Ovarian Cancer. Cancers. 12(7). 1761–1761. 8 indexed citations

Devaud, Christel, Anne‐Françoise Tilkin‐Mariamé, Alexandre Denadai‐Souza, et al.. (2019). FAK alternative splice mRNA variants expression pattern in colorectal cancer. International Journal of Cancer. 145(2). 494–502. 18 indexed citations

Devaud, Christel, Jennifer A. Westwood, Liza B. John, et al.. (2016). Abstract A105: Cross-talk between tumors can affect responses to therapy. Cancer Immunology Research. 4(1_Supplement). A105–A105.

Yong, Carmen S., Jennifer A. Westwood, Jan Schröder, et al.. (2015). Expression of a Chimeric Antigen Receptor in Multiple Leukocyte Lineages in Transgenic Mice. PLoS ONE. 10(10). e0140543–e0140543. 8 indexed citations

Devaud, Christel, Liza B. John, Jennifer A. Westwood, et al.. (2015). Cross-talk between tumors can affect responses to therapy.. PubMed. 4(7). e975572–e975572. 8 indexed citations

Devaud, Christel, Phillip K. Darcy, & Michael H. Kershaw. (2014). Foxp3 expression in T regulatory cells and other cell lineages. Cancer Immunology Immunotherapy. 63(9). 869–876. 71 indexed citations

10.

Devaud, Christel, Jennifer A. Westwood, Michele W.L. Teng, et al.. (2014). Differential potency of regulatory T cell-mediated immunosuppression in kidney tumors compared to subcutaneous tumors. OncoImmunology. 3(11). e963395–e963395. 6 indexed citations

11.

Devaud, Christel, Carmen S. Yong, Liza B. John, et al.. (2014). Foxp3 Expression in Macrophages Associated with RENCA Tumors in Mice. PLoS ONE. 9(9). e108670–e108670. 32 indexed citations

12.

Devaud, Christel, Benoı̂t Rousseau, Sonia Netzer, et al.. (2013). Anti-metastatic potential of human Vδ1+ γδ T cells in an orthotopic mouse xenograft model of colon carcinoma. Cancer Immunology Immunotherapy. 62(7). 1199–1210. 36 indexed citations

13.

John, Liza B., Christel Devaud, Connie P.M. Duong, et al.. (2013). Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells. Clinical Cancer Research. 19(20). 5636–5646. 571 indexed citations breakdown →

14.

Devaud, Christel, Liza B. John, Jennifer A. Westwood, Phillip K. Darcy, & Michael H. Kershaw. (2013). Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy. OncoImmunology. 2(8). e25961–e25961. 172 indexed citations

15.

Kershaw, Michael H., Christel Devaud, Liza B. John, Jennifer A. Westwood, & Phillip K. Darcy. (2013). Enhancing immunotherapy using chemotherapy and radiation to modify the tumor microenvironment. OncoImmunology. 2(9). e25962–e25962. 83 indexed citations

16.

Daburon, Sophie, Christel Devaud, Pierre Costet, et al.. (2013). Functional Characterization of a Chimeric Soluble Fas Ligand Polymer with In Vivo Anti-Tumor Activity. PLoS ONE. 8(1). e54000–e54000. 15 indexed citations

17.

Devaud, Christel, Jennifer A. Westwood, Liza B. John, et al.. (2013). Tissues in Different Anatomical Sites Can Sculpt and Vary the Tumor Microenvironment to Affect Responses to Therapy. Molecular Therapy. 22(1). 18–27. 98 indexed citations

18.

Duong, Connie P.M., Jennifer A. Westwood, Carmen S. Yong, et al.. (2013). Engineering T Cell Function Using Chimeric Antigen Receptors Identified Using a DNA Library Approach. PLoS ONE. 8(5). e63037–e63037. 46 indexed citations

19.

John, Liza B., Jacqueline K. Flynn, Alison C. West, et al.. (2012). Oncolytic Virus and Anti–4-1BB Combination Therapy Elicits Strong Antitumor Immunity against Established Cancer. Cancer Research. 72(7). 1651–1660. 92 indexed citations

20.

Pegram, Hollie J., Jennifer A. Westwood, Liza B. John, et al.. (2011). Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice. Cancer Immunology Immunotherapy. 60(5). 671–683. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact